United States
Canada
Latin America
Europe: Member state of EU
Europe: Non-member state of EU
Europe: Norway, Switzerland and UK
Africa
Asia: Other than South Korea and Singapore
South Korea
Singapore
Oceania
the others
This cell line produces human monoclonal 4G12 antibody (Ig lambda). The 4G12 antibody recognizes a glycoprotein with Mr = 65,000. Immunohistochemically, 4G12 reacts especially with lung carcinomas and with some malignant tumors.
Other Name
Animal
mouse x human
Strain
Genus
Species
Sex
Age
Identity
Tissue for Primary Cancer
antibody-producing hybridoma
Case history
Metastasis
Tissue Metastasized
Genetics
human lymphoid x mouse myeloma (P3U1)
Life Span
infinite
Crisis PDL
Morphology
round
Character
4G12 antibody, preferentially reacting with lung carcinoma-associated antigen
Classify
Established by
Taniguchi, M.
Registered by
Matushiro,Y.
Regulation for Distribution
Comment
Year
1986
Medium
RPMI1640 medium with 4% fetal bovine serum
Methods for Passages
gentle pipetting and dilution
Cell Number on Passage
Race
CO2 Conc.
5 %
Tissue Sampling
Tissue Type
hybridoma, lymphoid x myeloma
Detection of virus genome fragment by Real-time PCR
Establishment of internal-image anti-idiotype monoclonal antibodies to a human antibody to lung cancer. Saito H,Taniguchi M,Fukasawa T,Yamaguchi Y,Fujisawa T Cancer Immunol Immunother. 1997 Apr;44(2):83-7
Characterization of a human monoclonal antibody with broad reactivity to malignant tumor cells. Saito H,Uchiyama K,Nakamura I,Hiraoka H,Yamaguchi Y,Taniguchi M J Natl Cancer Inst. 1988 Jul 20;80(10):728-34